Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000336740 | SCV000333665 | benign | not specified | 2015-08-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000336740 | SCV000528296 | benign | not specified | 2016-10-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000527182 | SCV000650338 | benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Al Jalila Children’s Genomics Center, |
RCV000336740 | SCV001984745 | benign | not specified | 2019-12-15 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001795479 | SCV005267450 | benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001795479 | SCV002035536 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000336740 | SCV002038217 | benign | not specified | no assertion criteria provided | clinical testing |